Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q3 EPS of ($0.37), $0.08 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.